OPKO Health (OPK) Competitors

Ligand Pharmaceuticals (NASDAQ:LGND) and OPKO Health (NASDAQ:OPK) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

Which has more risk and volatility, LGND or OPK?

Ligand Pharmaceuticals has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500.

Is LGND or OPK more profitable?

OPKO Health has a net margin of -5.66% compared to Ligand Pharmaceuticals' net margin of -73.07%. OPKO Health's return on equity of -2.85% beat Ligand Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ligand Pharmaceuticals	-73.07%	-7.83%	-6.92%
OPKO Health	-5.66%	-2.85%	-1.82%

Do analysts recommend LGND or OPK?

Ligand Pharmaceuticals currently has a consensus price target of $147.17, indicating a potential upside of 13.53%. OPKO Health has a consensus price target of $2.75, indicating a potential upside of 102.21%. Given OPKO Health's higher possible upside, analysts plainly believe OPKO Health is more favorable than Ligand Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ligand Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
OPKO Health	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has preferable valuation & earnings, LGND or OPK?

Ligand Pharmaceuticals has higher earnings, but lower revenue than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Ligand Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ligand Pharmaceuticals	$167.13M	14.96	-$4.03M	-$7.12	-18.21
OPKO Health	$713.10M	1.51	-$53.22M	-$0.07	-19.43

Does the media prefer LGND or OPK?

In the previous week, Ligand Pharmaceuticals had 11 more articles in the media than OPKO Health. MarketBeat recorded 16 mentions for Ligand Pharmaceuticals and 5 mentions for OPKO Health. OPKO Health's average media sentiment score of 1.10 beat Ligand Pharmaceuticals' score of 0.79 indicating that OPKO Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ligand Pharmaceuticals	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OPKO Health	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of LGND or OPK?

91.3% of Ligand Pharmaceuticals shares are held by institutional investors. Comparatively, 64.6% of OPKO Health shares are held by institutional investors. 7.0% of Ligand Pharmaceuticals shares are held by company insiders. Comparatively, 49.7% of OPKO Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

OPKO Health beats Ligand Pharmaceuticals on 10 of the 16 factors compared between the two stocks.